Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer
- PMID: 22840462
- DOI: 10.1016/j.breast.2012.07.008
Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer
Abstract
Background: To quantify tumour angiogenesis, microvessel density (MVD) has been widely used. We here present a novel angiogenesis marker, microvessel proliferation (MVP), based on dual immunohistochemical staining of nestin and Ki-67. Immature endothelial cells express nestin, and when co-expressed with the proliferation marker Ki-67, the number of proliferating immature blood vessels can be measured.
Materials and methods: Microvessel proliferation was evaluated in 178 breast cancer samples and estimated by vascular proliferation index (VPI), the ratio between the number of vessels containing proliferating endothelial cells and the total number of immature vessels.
Results: High VPI was strongly associated with several markers of aggressive breast cancer, such as negative oestrogen receptor (ER) status (p = 0.003), high tumour cell proliferation by Ki-67 (p = 0.004), high p53 expression (p = 0.001), and five profiles for the basal-like phenotype (odds ratios (OR); range 3.4-6.3). Also, high VPI was significantly associated with interval detected breast cancer compared with screening detected lesions (p < 0.0005), and adverse outcome in univariate and multivariate survival analysis (p = 0.034 and p = 0.022, respectively).
Conclusion: Microvessel proliferation is a novel marker of ongoing angiogenesis and was associated with aggressive tumour features, basal-like phenotypes, interval presentation, and prognosis in this series of breast cancer.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Quantifying tumour vascularity in non-luminal breast cancers.J Clin Pathol. 2017 Sep;70(9):766-774. doi: 10.1136/jclinpath-2016-204208. Epub 2017 Mar 1. J Clin Pathol. 2017. PMID: 28249942
-
Vascular proliferation is a prognostic factor in breast cancer.Breast Cancer Res Treat. 2012 Jun;133(2):501-10. doi: 10.1007/s10549-011-1785-7. Epub 2011 Sep 27. Breast Cancer Res Treat. 2012. PMID: 21947750
-
Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.J Clin Pathol. 2012 Jan;65(1):64-8. doi: 10.1136/jclinpath-2011-200318. Epub 2011 Oct 29. J Clin Pathol. 2012. PMID: 22039288
-
Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.Int J Urol. 2015 Sep;22(9):806-15. doi: 10.1111/iju.12840. Epub 2015 Jul 7. Int J Urol. 2015. PMID: 26153072 Review.
-
Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.World J Gastroenterol. 2013 Jan 7;19(1):42-8. doi: 10.3748/wjg.v19.i1.42. World J Gastroenterol. 2013. PMID: 23326161 Free PMC article. Review.
Cited by
-
Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.Sci Rep. 2023 Oct 20;13(1):17949. doi: 10.1038/s41598-023-45158-4. Sci Rep. 2023. PMID: 37863961 Free PMC article.
-
Clinical pathologies of breast cancer in the elderly and youths and their prognosis.Pak J Med Sci. 2014 May;30(3):535-8. doi: 10.12669/pjms.303.4929. Pak J Med Sci. 2014. PMID: 24948974 Free PMC article.
-
Association Between Vascular Index Measured via Superb Microvascular Imaging and Molecular Subtype of Breast Cancer.Front Oncol. 2022 Mar 21;12:861151. doi: 10.3389/fonc.2022.861151. eCollection 2022. Front Oncol. 2022. PMID: 35387128 Free PMC article.
-
Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis.Cancer Cell Int. 2014 Jun 20;14:57. doi: 10.1186/1475-2867-14-57. eCollection 2014. Cancer Cell Int. 2014. PMID: 24966803 Free PMC article.
-
Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.J Pathol Clin Res. 2017 Sep 12;3(4):249-257. doi: 10.1002/cjp2.78. eCollection 2017 Oct. J Pathol Clin Res. 2017. PMID: 29085665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous